Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 5/20 | 0.77 |
| ▸ | GRIN1 | Q05586 | 6/20 | 0.64 |
| ▸ | GRIN2B | Q13224 | 6/20 | 0.64 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.64 |
| ▸ | OSBP | P22059 | 2/20 | 0.64 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.64 |
| ▸ | RORC | P51449 | 1/20 | 0.64 |
| ▸ | OSBP2 | Q969R2 | 1/20 | 0.64 |
| ▸ | CTSD | P07339 | 1/20 | 0.55 |
| ▸ | PTPN2 | P17706 | 2/20 | 0.54 |
| ▸ | SRD5A1 | P18405 | 3/20 | 0.53 |
| ▸ | USP2 | O75604 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6393986 | 1.00 | PTPN1 (0.77) | PTPN1GRIN1GRIN2BGRIN2AOSBP | |
| SCHEMBL6390390 | 0.92 | PTPN1 (0.65) | PTPN1GRIN1GRIN2BGRIN2AOSBP | |
| SCHEMBL6389203 | 0.92 | PTPN1 (0.65) | PTPN1GRIN1GRIN2BGRIN2AOSBP | |
| SCHEMBL6392696 | 0.87 | PTPN1 (0.68) | PTPN1GRIN1GRIN2BGRIN2AOSBP | |
| SCHEMBL6392319 | 0.87 | PTPN1 (0.68) | PTPN1GRIN1GRIN2BGRIN2AOSBP | |
| SCHEMBL11410953 | 0.87 | PTPN1 (0.76) | PTPN1GRIN1GRIN2AOSBPNR1H3 | |
| SCHEMBL6388375 | 0.86 | PTPN1 (0.84) | PTPN1NR1H3PTPN2USP2 | |
| SCHEMBL6392384 | 0.85 | PTPN1 (0.74) | PTPN1GRIN1GRIN2AOSBPNR1H3 | |
| SCHEMBL6393358 | 0.85 | PTPN1 (0.74) | PTPN1GRIN1GRIN2AOSBPNR1H3 | |
| SCHEMBL6389672 | 0.85 | PTPN1 (0.74) | PTPN1GRIN1GRIN2BGRIN2AOSBP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050004382-A1 | Meiosis regulating compounds | GRONDAHL CHRISTIAN (DK) | 2005-01-06 | — | — | US | disclosed |
| US-6759400-B2 | Meiosis regulating compounds | NOVO NORDISK A/S (DK) | 2004-07-06 | — | — | US | disclosed |
| EP-0946584-B1 | Meiosis regulating compounds | NOVO NORDISK AS (DK) | 2003-04-23 | — | — | EP | disclosed |
| US-20030032824-A1 | Meiosis regulating compounds | GRONDAHL CHRISTIAN (DK) | 2003-02-13 | — | — | US | disclosed |
| US-6486145-B2 | STEROL DERIVATIVE USEFUL IN TREATMENT OF FERTILITY | NOVO NORDISK A/S (DK) | 2002-11-26 | — | — | US | disclosed |
| US-20010005757-A1 | Meiosis regulating compounds | GRONDAHL CHRISTIAN (DK) | 2001-06-28 | — | — | US | disclosed |
| EP-0946584-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1999-10-06 | — | — | EP | disclosed |
| WO-1998028323-A1 | MEIOSIS REGULATING COMPOUNDS | NOVO NORDISK A/S (DK) | 1998-07-02 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030032824-A1 | Meiosis regulating compounds | MNS1, NR5A1, NASP | PTPN1 3032/4885GRIN1 4263/4885GRIN2B 4818/4885 |
| US-20010005757-A1 | Meiosis regulating compounds | MNS1, NR5A1, NASP | PTPN1 3032/4885GRIN1 4263/4885GRIN2B 4818/4885 |
| US-20050004382-A1 | Meiosis regulating compounds | NASP, MNS1, NR5A1 | PTPN1 3419/4885GRIN1 4613/4885GRIN2B 4815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.